Metastatic Prostate Small Cell Carcinoma
Information
- Disease name
- Metastatic Prostate Small Cell Carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04592237 | Active, not recruiting | Phase 2 | Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer | December 29, 2020 | December 31, 2025 |
| NCT04471974 | Recruiting | Phase 2 | ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer | January 26, 2021 | April 30, 2027 |